Patients with low-risk cervical cancer have similar rates of pelvic recurrence whether they undergo simple or radical hysterectomy, a new study suggests.
News
Researchers sought to determine the safety profile of olaparib plus bevacizumab for maintenance therapy in advanced ovarian cancer.
The sBLA is supported by data from the phase 3 NRG-GY018 trial, which included patients with stage III-IV or recurrent endometrial carcinoma whose cancer was either pMMR or dMMR.
Researchers conducted a feasibility study to determine whether dietary education could help patients reduce the incidence of hypomagnesemia in patients receiving platinum-based chemotherapy.
A meta-analysis revealed associations between metformin use and endometrial cancer in patients with type 2 diabetes.
Median progression-free and overall survival significantly longer with standard therapy plus atezolizumab.
Use of a dilator and/or engaging in sexual activity after treatment for cervical cancer reduced the risk of vaginal stenosis, but not vaginal dryness or bleeding.
Adding HIPEC to interval cytoreductive surgery improves long-term outcomes in stage III epithelial ovarian cancer, a phase 3 trial suggests.
Left ventricular ejection fraction data from the JAVELIN Ovarian 200 trial showed low cardiotoxicity in patients with ovarian cancer treated with avelumab, avelumab plus PLD, or PLD.
Screening can lead to earlier diagnosis of high-grade serous ovarian cancer, but this does not translate to a substantial improvement in survival, according to researchers.